Literature DB >> 19372199

Minireview: Obesity and breast cancer: the estrogen connection.

Margot P Cleary1, Michael E Grossmann.   

Abstract

There is now substantial evidence that overweight and/or obesity and/or weight gain are risk factors for the development of postmenopausal breast cancer. In addition, obesity and/or elevated body mass index at breast cancer diagnosis has a negative impact on prognosis for both premenopausal and postmenopausal women. Therefore, understanding the mechanism of how obesity affects the mammary tumorigenesis process is an important health issue. Elevated serum estrogen levels as well as enhanced local production of estrogen have been considered primary mediators of how increased body weight promotes breast cancer development in postmenopausal women. Here, we provide an overview of estrogen's relationship with both obesity and breast cancer as separate entities. Human and relevant preclinical studies are cited. In addition, other growth factors that may be involved in this relationship are considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372199      PMCID: PMC2689796          DOI: 10.1210/en.2009-0070

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  111 in total

1.  Case-control study of anthropometric measures and breast cancer risk.

Authors:  Christine M Friedenreich; Kerry S Courneya; Heather E Bryant
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

Review 2.  The relationship between obesity and breast cancer risk and mortality.

Authors:  Junaidah B Barnett
Journal:  Nutr Rev       Date:  2003-02       Impact factor: 7.110

3.  Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.

Authors:  S M Enger; R K Ross; A Paganini-Hill; C L Carpenter; L Bernstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-07       Impact factor: 4.254

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 5.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

6.  Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line.

Authors:  Stefania Catalano; Stefania Marsico; Cinzia Giordano; Loredana Mauro; Pietro Rizza; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

7.  Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women.

Authors:  Sonia M Boyapati; Xiao Ou Shu; Yu-Tang Gao; Qi Dai; Herbert Yu; J R Cheng; Fan Jin; Wei Zheng
Journal:  Cancer Causes Control       Date:  2004-04       Impact factor: 2.506

Review 8.  Obesity and breast cancer: a review of the literature.

Authors:  A R Carmichael; T Bates
Journal:  Breast       Date:  2004-04       Impact factor: 4.380

9.  Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice.

Authors:  Soner Dogan; Xin Hu; Yan Zhang; Nita J Maihle; Joseph P Grande; Margot P Cleary
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

Authors:  Amitabha Ray; Katai J Nkhata; Margot P Cleary
Journal:  Int J Oncol       Date:  2007-06       Impact factor: 5.650

View more
  170 in total

1.  Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.

Authors:  Min Zhao; Patrick C Sachs; Xu Wang; Catherine I Dumur; Michael O Idowu; Valentina Robila; Michael P Francis; Joy Ware; Matthew Beckman; Aylin Rizki; Shawn E Holt; Lynne W Elmore
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

Review 2.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 3.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

4.  Menopause is a determinant of breast adipose inflammation.

Authors:  Neil M Iyengar; Patrick G Morris; Xi Kathy Zhou; Ayca Gucalp; Dilip Giri; Michael D Harbus; Domenick J Falcone; Margaret D Krasne; Linda T Vahdat; Kotha Subbaramaiah; Monica Morrow; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-26

5.  Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.

Authors:  Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester
Journal:  Breast Cancer Res Treat       Date:  2011-10-15       Impact factor: 4.872

Review 6.  Analysis of estrogens and androgens in postmenopausal serum and plasma by liquid chromatography-mass spectrometry.

Authors:  Qingqing Wang; Lisa Bottalico; Clementina Mesaros; Ian A Blair
Journal:  Steroids       Date:  2014-08-20       Impact factor: 2.668

7.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

8.  Complex organochlorine pesticide mixtures as determinant factor for breast cancer risk: a population-based case-control study in the Canary Islands (Spain).

Authors:  Luis D Boada; Manuel Zumbado; Luis Alberto Henríquez-Hernández; Maira Almeida-González; Eva E Alvarez-León; Lluis Serra-Majem; Octavio P Luzardo
Journal:  Environ Health       Date:  2012-04-25       Impact factor: 5.984

9.  Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk.

Authors:  H Zhao; J Wang; D Fang; O Lee; R T Chatterton; V Stearns; S A Khan; S E Bulun
Journal:  Horm Cancer       Date:  2018-03-15       Impact factor: 3.869

10.  Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.

Authors:  Patrick G Morris; Xi Kathy Zhou; Ginger L Milne; Daniel Goldstein; Laura C Hawks; Chau T Dang; Shanu Modi; Monica N Fornier; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.